Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2003
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097799A2 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS
11/27/2003WO2003097714A1 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid
11/27/2003WO2003097698A1 Treatment of cancer by the use of anti fas antibody
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097602A1 Cyanoguanidine produgs
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097110A1 Therapeutic target and uses thereof
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097100A1 Topical composition for the treatment of inflammatory conditions of the skin
11/27/2003WO2003097099A1 Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097095A1 Process for the preparation and activation of substances and a means of producing same
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097067A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097064A1 Therapeutic agent for diabetes
11/27/2003WO2003097057A1 Synergistic combination of an opioid analgesic and a nsaid
11/27/2003WO2003097056A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097051A2 Use of compounds that are effective as selective opiate receptor modulators
11/27/2003WO2003097050A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003WO2003097049A1 Anti-estrogen receptor agents for chemotherapy and prevention
11/27/2003WO2003097046A1 Method for treating obesity
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003097044A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097035A1 Non-steroidal anti-androgen therapy
11/27/2003WO2003097028A1 Use of edg receptor binding agents in cancer
11/27/2003WO2003097024A1 Methods for the prevention and/or the treatment of neurological disorders
11/27/2003WO2003097012A1 Co-grinding process for the preparation of a ternary composition
11/27/2003WO2003097011A1 Compositions and methods using proton pump inhibitors
11/27/2003WO2003097010A1 Medicinal preparation in a colloid for topical application in the therapy and prophylaxis of states of pain and itching
11/27/2003WO2003097000A1 Composition for enhancing oral health
11/27/2003WO2003096980A2 Bicyclic modulators of androgen receptor function
11/27/2003WO2003096977A2 Methods of treating hepatitis
11/27/2003WO2003096970A2 Methods and compositions for treating t cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency
11/27/2003WO2003082189A3 Method for producing pseudo islets
11/27/2003WO2003080638A9 Antisense iap nucleobase oligomers and uses thereof
11/27/2003WO2003075841A3 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
11/27/2003WO2003070157A3 Vitamin d upregulated protein 1 (vdup-1) methods and uses thereof
11/27/2003WO2003066807A9 Method of inhibiting pathogenicity of infectious agents
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003063876A3 Methods of treating patients suffering from movement disorders
11/27/2003WO2003061702A9 Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunsuppressor and anti-inflammatory agent
11/27/2003WO2003059378A3 Combined use of a glp-1 compound and another drug for treating dyslipidemia
11/27/2003WO2003059271A3 Treatment involving peroxisome proliferator-activated receptor-gamma agonist and cyclooxygenase-2 selective inhibitors
11/27/2003WO2003056899A3 Nitric oxide donors for treatment of disease and injury
11/27/2003WO2003055505A3 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
11/27/2003WO2003042344A3 Apo2 ligand/trail formulations
11/27/2003WO2003032965A3 Use of ace inhibitors for reducing type 2 diabetes in high risk patients
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003030832A3 Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003028656A3 Adjuvant compositions
11/27/2003WO2003022852A3 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003006995A3 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/27/2003WO2003006611A3 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003WO2002099059A3 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/27/2003WO2002094283A3 Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002069987A3 Agent for treating diabetes mellitus
11/27/2003WO2002066617A8 Method for detecting a risk of hypertension and uses thereof
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002060393B1 Proteoglycan compositions for treatment of inflammatory conditions
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003WO2000050046A8 Stabilized oral pharmaceutical composition containing iodide and iodate and method
11/27/2003US20030221207 Cardiac-specific 11beta hydroxysteroid dehydrogenase type 2 transgenic mice
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia
11/27/2003US20030220376 Administering a carbo or heterocyclic compound having a sulfonamide group to a patient to treat carbonic anhydrase mediated diseases such as elevated intraocular pressure, edema, altitude sickness and periodic paralyis
11/27/2003US20030220374 Thiazolidinediones or oxazolidinediones as peroxisome proliferator-activated receptor-gamma agonist, useful for treating or inhibiting pain, inflammation, or inflammation related disease and inhibition of cancer
11/27/2003US20030220373 Therapeutic uses of PPAR mediators
11/27/2003US20030220366 Nicotinamide derivatives useful as PDE4 inhibitors
11/27/2003US20030220364 New compounds
11/27/2003US20030220363 L-carnitine or salt exerts an adjuvant action for the anticancer activity
11/27/2003US20030220361 Administering together tiotropium salt and substituted 3-amidopyridine derivatives for treating inflammation, allergic and respiratory diseases
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
1 ... 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 ... 1151